Keck Biotechnology Lab

Keck Mass Spectrometry Resource

Yale/NHLBI Proteomics Center

High Performance Computation


Site Index:


Yale/NIDA
Proteomics Center


Yale University
300 George Street
New Haven, CT 06511


Contact Us

   Yale University School of Medicine

NIDA Proteomics CenterFact Sheet

Yale/NIDA Neuroproteomics Center Fact Sheet

 
Title of Center Grant: Yale/NIDA Neuroproteomics Research Center
Grant Number: 1 P30 DA018343-01
Theme of Center: "Proteomics of Altered Signaling in Addiction"
Principal Investigator: Kenneth R. Williams, Ph.D.
Director, W.M. Keck Foundation
Biotechnology Resource Laboratory
Professor (Adj,) Research
Dept. of Molecular Biophysics & Biochemistry
Yale University School of Medicine
Co-Principal Investigator: Angus C. Nairn, Ph.D.
Professor, Department of Psychiatry
Yale University School of Medicine
Awarding Agency: National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
#Grants Awarded: 2
Total Funding Awarded to Yale: $7.7 million
Total Budget Period: 8/23/2004 – 5/31/2009
Center Cores: Administrative, Bioinformatics and Biostatistics, Protein Identification, Protein Microarray; and Protein and Lipid Separation and Profiling
Center Investigators: 14 from Yale University, the Veterans Administration Medical Center (West Haven, CT) and Rockefeller University
Specific Aims:
  • Bring together Yale faculty working at the forefront of such key neuroscience areas as signal transduction, plasticity, neuronal morphogenesis, lipid metabolism in neuronal signaling and synaptic function, and response to psychotropic drugs with experts in proteomics, biostatistics, and bioinformatics.
  • Apply high-throughput, state-of-the-art proteomic technologies like MALDI-MS based biomarker analysis, two-dimensional chromatography, differential (fluorescence) gel electrophoresis (DIGE), isotope-coded affinity tag (ICAT), and antibody microarrays to analyze adaptive changes in neuronal protein expression and regulation that occur in response to drugs of abuse.
  • To advance and develop new separation tools for cellular lipids and neuroproteomic technologies for studying the brain phosphoproteome and apply these to studies of the actions of drugs of abuse.
  • Analyze the actions of opiates; the psychostimulants, cocaine and amphetamine; and nicotine on protein expression.
  • Study the proteomic changes that occur both pre- and post-synaptically following the actions of drugs of abuse.
Overall Goal: To substantially increase understanding of the biochemical mechanisms that underlie substance abuse and its treatment.

    Top of Page
Medical Center

Yale-New Haven Hospital

Yale University

Copyright © 2004, Yale University, New Haven, Connecticut, USA. All rights reserved.
Comments or suggestions to Greg Blasko.

Last modified: 02-May-2005 (GB)